Selective Vasodilator Effects of Atrial Natriuretic Peptide in the Human Placental Vasculature

Gershon Holcberg, Wilhelm Kossenjans, Anthony Brewer, Menachem Miodovnik, Leslie Myatt

Resultado de la investigación: Articlerevisión exhaustiva

11 Citas (Scopus)

Resumen

Objective: To determine whether atrial natriuretic peptide (ANP) attenuates the vasocon-strictor effects of angiotensin II (AII), a thromboxane mimetic (U46619), and endothelin-1 in the human fetal-placental vasculature and to determine whether nitric oxide (NO) has a role in the vasodilator activity of ANP. Methods: Isolated placental cotyledons were dually perfused, with fetal perfusion pressure used as an index of vascular response. The effects of AII (10-10-10-6 mol/L bolus injection), endothelin-1 (10-7 mol/L bolus), and U46619 (10-9-10-6 mol/L bolus or 10-8 mol/L infusion) were established in the absence or presence of ANP (10-8 mol/L). The role of NO as a mediator of ANP action was investigated by perfusion with n-nitro-L-arginine (NNLA, 10-3 mol/L), an inhibitor of NO synthase. Statistical significance was determined by analysis of variance. Results: Atrial nutriuretic peptide caused significant attenuation of vasoconstrictor responses to AII, but weak attenuation of endothelin-1 and no attenuation of U46619. Use of NNLA did not affect the attenuation of AII-induced vasoconstriction by ANP. Conclusion: Atrial natriuretic peptide is a vasodilator of the fetal-placental vasculature constricted with AII and endothelin-1, but not with U46619. Nitric oxide does not mediate the action of ANP.

Idioma originalEnglish (US)
Páginas (desde-hasta)1-5
Número de páginas5
PublicaciónJournal of the Society for Gynecologic Investigation
Volumen2
N.º1
DOI
EstadoPublished - ene. 1995

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Huella

Profundice en los temas de investigación de 'Selective Vasodilator Effects of Atrial Natriuretic Peptide in the Human Placental Vasculature'. En conjunto forman una huella única.

Citar esto